SLC16A2 mutations in two Japanese patients with Allan-Herndon-Dudley syndrome

9Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Allan-Herndon-Dudley syndrome (AHDS) is a neurodevelopmental disorder that manifests as intellectual disability and motor developmental delay. Thyroid hormone transporter dysfunction due to SLC16A2 mutation is the underlying cause of this disorder. We identified a novel (P537del) and a recurrent (A150V) SLC16A2 mutation in Japanese AHDS patients from two different families. A150V co-segregated with S33P. Both patients showed similar clinical features including severe neurological features and delayed myelination. Thyroid function showed a common finding of elevated T3 levels. No clear genotype-phenotype correlation was observed in patients with SLC16A2 alterations.

Cite

CITATION STYLE

APA

Yamamoto, T., Shimojima, K., Umemura, A., Uematsu, M., Nakayama, T., & Inoue, K. (2014). SLC16A2 mutations in two Japanese patients with Allan-Herndon-Dudley syndrome. Human Genome Variation, 1. https://doi.org/10.1038/hgv.2014.10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free